NKTR-214 & Nivolumab: Synergistic Activity Across Tumor Types
EP. 1: Who Is Winning the War on Cancer?
July 11th 2018
EP. 2: The Hype and the Hope of Immuno-Oncology Agents
July 11th 2018
EP. 3: Synergistic Activity of NKTR-214 With Nivolumab
July 11th 2018
EP. 4: The PIVOT-02 Trial: NKTR-214 With Nivolumab
July 11th 2018
EP. 5: Pathophysiology of the Tumor Microenvironment in Melanoma
July 11th 2018
EP. 6: Pegylation Chemistry of NKTR-214 in Melanoma
July 11th 2018
EP. 7: PIVOT-02 for First-Line Stage IV Melanoma
July 11th 2018
EP. 8: Biomarker Sampling in Metastatic Melanoma
July 11th 2018
EP. 9: Efficacy of NKTR-214 in the Tumor Microenvironment
July 11th 2018
EP. 10: PIVOT-02: Implications and Next Steps in Research
July 11th 2018
